NASDAQ:RBPAA

Royal Bancshares of Pennsylvania (RBPAA) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$4.48
$4.55
50-Day Range
N/A
52-Week Range
$3.13
$4.87
Volume
22,261 shs
Average Volume
60,237 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Royal Bancshares of Pennsylvania

Royal Bancshares of Pennsylvania, Inc. is a bank holding company. The Company offers a range of financial and banking products and services. The principal activities of the Company are supervising Royal Bank America (Royal Bank), which engages in general banking business. It operates through two segments: Community Banking and Tax Liens. Its community banking segment consists of commercial and retail banking and equipment leasing. The community banking business segment includes Royal Bank and Royal Bank Leasing, and offers a range of products and services. Its tax liens segment includes ownership interest in Crusader Servicing Corporation and Royal Tax Lien Services, LLC. Royal Bank conducts business operations as a commercial bank offering consumer and business deposit products and services, and commercial and consumer loans, including home equity and small business administration loans. It also offers a range of services, such as cash management products and mobile deposits.

RBPAA Stock News Headlines

RBC Capital Reaffirms Their Hold Rating on Prosperity Bancshares (PB)
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
How to Start an LLC in Pennsylvania (2024 Guide)
Tamara Johnson
Trump to address NRA members in Pennsylvania
Royal wedding 2018: Order of service
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
John R. Young
Michelle M. Forcina
Lindsay J. Achs
Sierra D. Cuppett
Best Hospitals in Pennsylvania
HWBK - Hawthorn Bancshares, Inc.
University of Pennsylvania (Wharton)
Royal Palace of Madrid (Palacio Real)
Bank M&A Complicated by Failures
See More Headlines
Receive RBPAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Royal Bancshares of Pennsylvania and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:RBPAA
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Robert R. Tabas (Age 60)
    Chairman of the Board
  • Frank Kevin Tylus (Age 61)
    President, Chief Executive Officer, Director
  • Michael S. Thompson (Age 44)
    Chief Financial Officer
  • Mark W. Biedermann
    Executive Vice President, Chief Lending Officer
  • Lars B. Eller (Age 48)
    Executive Vice President, Chief Retail Officer
  • Linda Tabas Stempel (Age 64)
    Director
  • Murray Stempel III (Age 61)
    Director
  • Howard J. Wurzak (Age 61)
    Director
  • Edward F. Bradley CPA (Age 72)
    Independent Director
  • Wayne R. Huey Jr. (Age 71)
    Independent Director

This page (NASDAQ:RBPAA) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners